29 results on '"Lee, Sue H."'
Search Results
2. Structure–Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors
3. Discovery of Nonlipogenic ABCA1 Inducing Compounds with Potential in Alzheimer’s Disease and Type 2 Diabetes
4. Interaction of oxidative stress and neurotrauma in ALDH2 mice causes significant and persistent behavioral and pro-inflammatory effects in a tractable model of mild traumatic brain injury
5. P1-087: DEVELOPMENT OF MULTIFUNCTIONAL ABCA1 INDUCERS AS ALZHEIMER'S DISEASE THERAPEUTICS
6. P3-062: CALPAIN-1 IN NEURODEGENERATION: EVALUATING THERAPEUTIC EFFICACY OF INHIBITION STRATEGIES
7. Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery
8. O5‐06‐02: OPTIMIZATION OF TISSUE‐SELECTIVE ABCA1 AGONISTS (TSAAGS) AS AN EFFECTIVE AND TOLERATED THERAPY FOR ALZHEIMER'S DISEASE
9. P1‐220: SELECTIVE CALPAIN‐1 VERSUS CALPAIN‐1/CATHEPSIN‐B DUAL INHIBITION AS A THERAPEUTIC APPROACH TO AD
10. P1‐074: TISSUE‐SELECTIVE ABCA1 AGONISTS AS POTENTIAL ALZHEIMER'S DISEASE THERAPEUTICS: HIT‐TO‐LEAD OPTIMIZATION
11. Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors
12. Soluble guanylyl cyclase is a critical regulator of migraine-associated pain
13. DEVELOPMENT OF MULTIFUNCTIONAL ABCA1 INDUCERS AS ALZHEIMER’S DISEASE THERAPEUTICS
14. P4-101: Chemoproteomic Approach to Characterizing the Role of 4-HNE in Accelerated Cognitive Impairment
15. P1-035: NO/CGMP/CREB-Based Synaptic Repair as a Multifunctional Therapeutic Approach to Disease Modification in Multiple Familial Mouse Models and a Novel Sporadic Model Of Alzheimer's Disease
16. Erratum to: A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer’s disease
17. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer’s disease
18. OPTIMIZATION OF TISSUE-SELECTIVE ABCA1 AGONISTS (TSAAGS) AS AN EFFECTIVE AND TOLERATED THERAPY FOR ALZHEIMER’S DISEASE
19. SELECTIVE CALPAIN-1 VERSUS CALPAIN-1/CATHEPSIN-B DUAL INHIBITION AS A THERAPEUTIC APPROACH TO AD
20. TISSUE-SELECTIVE ABCA1 AGONISTS AS POTENTIAL ALZHEIMER'S DISEASE THERAPEUTICS: HIT-TO-LEAD OPTIMIZATION
21. Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia
22. Amyloid-β Pathology and APOE Genotype Modulate Retinoid X Receptor Agonist Activity in Vivo
23. CHEMOPROTEOMIC APPROACH TO CHARACTERIZING THE ROLE OF 4-HNE IN ACCELERATED COGNITIVE IMPAIRMENT
24. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.
25. Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.
26. Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia
27. NO/CGMP/CREB-BASED SYNAPTIC REPAIR AS A MULTIFUNCTIONAL THERAPEUTIC APPROACH TO DISEASE MODIFICATION IN MULTIPLE FAMILIAL MOUSE MODELS AND A NOVEL SPORADIC MODEL OF ALZHEIMER'S DISEASE.
28. Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.
29. Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer's Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.